Form 8-K - Current report:
SEC Accession No. 0001558370-24-015884
Filing Date
2024-11-21
Accepted
2024-11-21 09:15:22
Documents
13
Period of Report
2024-11-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K dwtx-20241115x8k.htm   iXBRL 8-K 39906
  Complete submission text file 0001558370-24-015884.txt   161554

Data Files

Seq Description Document Type Size
2 EX-101.SCH dwtx-20241115.xsd EX-101.SCH 3248
3 EX-101.LAB dwtx-20241115_lab.xml EX-101.LAB 15931
4 EX-101.PRE dwtx-20241115_pre.xml EX-101.PRE 10046
15 EXTRACTED XBRL INSTANCE DOCUMENT dwtx-20241115x8k_htm.xml XML 4900
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Dogwood Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

EIN.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39811 | Film No.: 241482329
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)